Clinical Study "Common" Name (formal title)	Number of enrollees	Funding source (pharma/NIH)	Year complete	Primary publication	Full study treatment protocol
DRCR Retina Network Protocol S (Panretinal Photocoagulation Vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial)	394 eyes	National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. Genentech provided ranibizumab for the study and funds to defray the studys clinical site costs.	2015	Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, et al. Panretinal photocoagulation vs Intravenous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. JAMA. 2015;314(20):2137-2146. https://jamanetwork.com/journals/jama/fullarticle/2469891